ReviewCardiovascular diabetology2024

Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives.

Kosuke Sawami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.